Literature DB >> 3092864

Human factor VIII: purification from commercial factor VIII concentrate, characterization, identification and radiolabeling.

R J Hamer, J A Koedam, N H Beeser-Visser, J J Sixma.   

Abstract

Human factor VIII was purified from commercial factor VIII concentrate with a 12% yield. The specific coagulant activity of purified factor VIII was 8,000 units/mg. In the presence of SDS the purified factor VIII consisted of a variety of polypeptides on polyacrylamide gels, ranging between Mr 80,000 and Mr 208,000. In the absence of SDS the purified factor VIII showed an apparent molecular weight of 270,000 upon Sephadex G200 gel-filtration. The purified factor VIII could be activated by thrombin, which resulted in the disappearance of Mr 108,000-208,000 polypeptides in favor of an Mr 92,000 polypeptide. Treatment with factor Xa also activated factor VIII, whereas treatment with activated protein C resulted in the inactivation of coagulant activity. Coagulant-active 125I-factor VIII was prepared using a lactoperoxidase radioiodination procedure. This 125I-factor had the same characteristics as unlabeled factor VIII. All polypeptides could be precipitated with monoclonal antibodies directed against factor VIII. With 125I-factor VIII a pIapp of 5.7 was found in the presence of urea.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092864     DOI: 10.1016/0167-4838(86)90084-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Electron microscopy of human factor V and factor VIII: correlation of morphology with domain structure and localization of factor V activation fragments.

Authors:  W E Fowler; P J Fay; D S Arvan; V J Marder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.

Authors:  M W Mosesson; D N Fass; P Lollar; J P DiOrio; C G Parker; G J Knutson; J F Hainfeld; J S Wall
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.

Authors:  J J Zwaginga; H A Koomans; J J Sixma; T J Rabelink
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

4.  Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

Authors:  J A Koedam; J C Meijers; J J Sixma; B N Bouma
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

5.  P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells.

Authors:  J A Koedam; E M Cramer; E Briend; B Furie; B C Furie; D D Wagner
Journal:  J Cell Biol       Date:  1992-02       Impact factor: 10.539

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.